26.03.2024 • News

Dow to Build World-Scale Carbonate Solvents Facility on US Gulf Coast

Dow announced its intent to build a world-scale carbonate solvents production facility for lithium-ion battery production on the US Gulf Coast. The plant will serve customers in the lithium-ion battery sector, in which carbonate solvents are used as a component in electrolytes.

According to Dow, the project is supported by agreements with customers, including leading electric vehicle original equipment manufacturers and electrolyte manufacturers. The facility is to produce carbonate solvents by capturing over 90% of carbon dioxide emissions from the ethylene oxide manufacturing process.

Dow is collaborating with the US Department of Energy (DOE) to negotiate an award for the project from the Office of Clean Energy Demonstrations (OCED).

"This announcement is an exciting proof point of Dow's Decarbonize & Grow strategy, paired with our MobilityScience capabilities and commitment to a sustainable future for the automotive industry," said Brendy Lange, Dow Industrial Solutions business vice president. "The support from the DOE is a critical enabler of this project, localizing the supply of low-carbon value-added products to help enable the clean energy transition while advancing the decarbonization of our own operations," Lange added.

© Getty Images
© Getty Images

Company

Logo:

Dow Chemical Company

2211 HH Dow Way
48674 Midland, MI
US

Company contact







Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read